"永信" 更順糖衣錠0.625毫克

国家: 台湾

语言: 中文

来源: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

资料单张 资料单张 (PIL)
04-03-2021
公众评估报告 公众评估报告 (PAR)
28-03-2020

有效成分:

ESTROGEN CONJUGATED

可用日期:

永信藥品工業股份有限公司 台中市大甲區頂店里中山路一段1191號 (56065601)

ATC代码:

G03CA57

药物剂型:

糖衣錠

组成:

ESTROGEN CONJUGATED (6816000401) MG

每包单位数:

塑膠瓶裝;;鋁箔盒裝

类:

製 劑

处方类型:

須由醫師處方使用

厂商:

永信藥品工業股份有限公司台中幼獅廠 台中市大甲區日南里工七路9號、工九路27號 TW

治疗领域:

conjugated estrogens

疗效迹象:

與停經有關血管性症狀、萎縮性陰道炎、骨質疏鬆症、女陰乾皺、女性生殖腺官能不足、原發性卵巢衰竭、荷爾蒙不平衡官能異常性子宮出血。

產品總結:

有效日期: 2027/02/27; 英文品名: PMS Sugar-Coated Tablets 0.625mg "Yung Shin"

授权日期:

2007-02-27

资料单张

                                ECT-002
048592
!
0.625
PMS
Sugar-Coated Tablets 0.625mg
"Yung Shin"
Conjugated Estrogen
ertrone, equilin
17 alpha-dihydroequilin
17 alpha-estradiol, equilenin
17 alpha-dihydroequilenin,
17 beta-dihydroequilin, 17 beta-estradiol
delta 8, 9-dehydroestrone
Conjugated Estrogen
..............................................................
0.625 mg
Microcrystalline Cellulose
Magnesium Stearate
Calcium Phosphate
Dibasic 2H2O Gelatin
Tartrazine
Cochineal Red A Titanium Dioxide
Talc
Hydroxyethylcellulose HHX
Hydroxypropyl methylcellulose
Colloidal Silicon Dioxide
Magnesium Aluminosilicate UFL2
Hydroxypropylmethylcellulose Phthalate
Acacia
Indigocarmine
Sugar
Conjugated Estrogen
(WHI)
27,000
0.625mg
0.625mg/2.5mg
medroxyprogesterone
acetate
(CHD)
CHD
CHD
(PE)
16,608
63
50
79
5.2
a
JAMA, 2002; 288:321-333
b
(situ breast cancer)
c
10,000
7
8
8
8
10,000
6
5
10,000
19
(alternative treatment)
1.
2.
3.
4.
5.
6.
7.
8.
⁄
VTE
WHI
⁄
37
30
10,000
WHI
⁄
29
21
10,000
WHI
N = 2,763
66.7
HERS
CONJUGATED EQUINE ESTROGEN PLUS MPA
4 . 1
CONJUGATED
EQUINE ESTROGEN PLUS MPA
4.1
CONJUGATED EQUINE ESTROGEN PLUS MPA
HERS
2,321
HERS
2.7
HERS
6.8
HERS
HERS
WHI
⁄
10,000
34
10,000
16
WHI
2
12
5
10
15
24
8
15
WHI
5.2
⁄
WHI
5.2
26
10,000
38
30
4
WHI
5.2
51
1,000
50
5
10
15
70
2
6
12
1,000
45
WHI
a
vs.
5.2
(95% CI*)
1.29 (1.02-1.63)
30
37
(CHD)
N
8102
N
8506
1.32 (1.02-1.72)
23
30
1.18 (0.70-1.97)
6
7
CHD
1.26 (1.00-1.59)
30
38
b
1.41 (1.07-1.85)
21
29
2.13 (1.39-3.25)
8
16
0.63 (0.43-0.92)
16
10
0.83 (0.47-1.47)
6
5
0.66 (0.45-0.98)
15
10
0.92 (0.74-1.14)
40
37
1.15 (1.03-1.28)
151
170
2.07 (1.49-2.87)
13
26
c
0.66 (0.44-0.98)
15
9
c
0.77 (0.69-0.86)
170
131
c
10,000
2153785
®
®
®
(WHI)
5.2
(1)
(2)
(HDL)
(LDL)
(3)
—
CIOMS
VERY COMMON
10%
COMMON
1% AND
10%
UNCOMMON
0.1% AND
1%
RARE
0.01% AND
0.1%
VERY RARE
0.01%
⁄
X
(CASE-CONTROL)
(COHORT STUDIES)
10
10
10,000
4.4
10,000
6.5
2
4
10
⁄
⁄
MEDROXYPROGESTERONE ACETATE
17Β-ESTRADIOL
CYTOCHROME P450 3A4 (CYP3A4)
CYP3A4
PHENOBARBITAL, PHENYTOIN, CARBAMAZEPINE,
RIFAMPICIN
DEXAMETHASONE
17
                                
                                阅读完整的文件